Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James E Talmadge

Showing results (1-10 of 80) with videos related to

Pageof 8
Sort By:
International Immunopharmacology|February 26, 2020
A discussion on considerations in scientific integrityJames E Talmadge
Cancer Biology & Therapy|March 26, 2011
Bioluminescence in drug development for cancer: shedding light on therapeutic efficacyJames E Talmadge
Methods in Molecular Biology (Clifton, N.J.)|December 17, 2009
Models of metastasis in drug discoveryJames E Talmadge
Idrugs : the Investigational Drugs Journal|February 8, 2007
American Society of Hematology--48th Annual Meeting and Exposition. Treatments for leukemia and lymphoma. 9-12 December 2006 Orlando, FL, USAJames E Talmadge
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2007
Pathways mediating the expansion and immunosuppressive activity of myeloid-derived suppressor cells and their relevance to cancer therapyJames E Talmadge
International Immunopharmacology|July 16, 2003
Hematopoietic stem cell graft manipulation as a mechanism of immunotherapyJames E Talmadge
International Immunopharmacology|March 13, 2016
Natural product derived immune-regulatory agentsJames E Talmadge
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2008
Follistatin as an inhibitor of experimental metastasisJames E Talmadge
Idrugs : the Investigational Drugs Journal|April 2, 2004
Gene therapy of cancer - 12th International ConferenceJames E Talmadge
Seminars in Cancer Biology|December 15, 2010
Immune cell infiltration of primary and metastatic lesions: mechanisms and clinical impactJames E Talmadge
Pageof 8

Showing results (1-10 of 80) with videos related to

Sort By:
Pageof 8
International Immunopharmacology|February 26, 2020
A discussion on considerations in scientific integrityJames E Talmadge
Cancer Biology & Therapy|March 26, 2011
Bioluminescence in drug development for cancer: shedding light on therapeutic efficacyJames E Talmadge
Methods in Molecular Biology (Clifton, N.J.)|December 17, 2009
Models of metastasis in drug discoveryJames E Talmadge
Idrugs : the Investigational Drugs Journal|February 8, 2007
American Society of Hematology--48th Annual Meeting and Exposition. Treatments for leukemia and lymphoma. 9-12 December 2006 Orlando, FL, USAJames E Talmadge
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2007
Pathways mediating the expansion and immunosuppressive activity of myeloid-derived suppressor cells and their relevance to cancer therapyJames E Talmadge
International Immunopharmacology|July 16, 2003
Hematopoietic stem cell graft manipulation as a mechanism of immunotherapyJames E Talmadge
International Immunopharmacology|March 13, 2016
Natural product derived immune-regulatory agentsJames E Talmadge
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2008
Follistatin as an inhibitor of experimental metastasisJames E Talmadge
Idrugs : the Investigational Drugs Journal|April 2, 2004
Gene therapy of cancer - 12th International ConferenceJames E Talmadge
Seminars in Cancer Biology|December 15, 2010
Immune cell infiltration of primary and metastatic lesions: mechanisms and clinical impactJames E Talmadge
Pageof 8